APA (7th ed.) Citation

Y, Z., Y, Y., Z, D., Y, S., M, Z., W, L., . . . J, Z. (2026). Rosiglitazone hepatotoxicity resulting from hepatic protein covalent binding derived from its aldehyde metabolite. Archives of toxicology, 100(8), 3667. https://doi.org/10.1007/s00204-026-04382-3

Chicago Style (17th ed.) Citation

Y, Zhao, et al. "Rosiglitazone Hepatotoxicity Resulting from Hepatic Protein Covalent Binding Derived from Its Aldehyde Metabolite." Archives of Toxicology 100, no. 8 (2026): 3667. https://doi.org/10.1007/s00204-026-04382-3.

MLA (9th ed.) Citation

Y, Zhao, et al. "Rosiglitazone Hepatotoxicity Resulting from Hepatic Protein Covalent Binding Derived from Its Aldehyde Metabolite." Archives of Toxicology, vol. 100, no. 8, 2026, p. 3667, https://doi.org/10.1007/s00204-026-04382-3.